Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

Sep 21, 2023

SELL
$63.15 - $90.42 $2.2 Million - $3.15 Million
-34,800 Reduced 23.23%
115,000 $8.98 Million
Q1 2022

May 16, 2022

SELL
$63.15 - $90.42 $2.2 Million - $3.15 Million
-34,800 Reduced 23.23%
115,000 $8.98 Million
Q4 2021

Sep 21, 2023

BUY
$77.28 - $99.42 $9.23 Million - $11.9 Million
119,400 Added 392.76%
149,800 $13.5 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $9.23 Million - $11.9 Million
119,400 Added 392.76%
149,800 $13.5 Million
Q4 2020

Sep 21, 2023

SELL
$125.56 - $178.74 $10.6 Million - $15.1 Million
-84,600 Reduced 73.57%
30,400 $5.18 Million
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $1.95 Million - $2.77 Million
15,500 Added 104.03%
30,400 $5.18 Million
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $551,946 - $881,987
6,700 Added 81.71%
14,900 $1.46 Million
Q4 2019

Feb 13, 2020

SELL
$76.53 - $135.58 $2.69 Million - $4.76 Million
-35,100 Reduced 81.06%
8,200 $1.06 Million
Q3 2019

Nov 13, 2019

SELL
$72.81 - $156.91 $502,389 - $1.08 Million
-6,900 Reduced 13.75%
43,300 $3.26 Million
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $4.51 Million - $6.11 Million
40,200 Added 402.0%
50,200 $7.63 Million
Q1 2019

May 15, 2019

SELL
$106.67 - $151.68 $3.16 Million - $4.49 Million
-29,600 Reduced 74.75%
10,000 $1.19 Million
Q4 2018

Feb 14, 2019

BUY
$97.32 - $148.76 $778,560 - $1.19 Million
8,000 Added 25.32%
39,600 $4.32 Million
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $2.35 Million - $3.29 Million
-20,400 Reduced 39.23%
31,600 $5.1 Million
Q2 2018

Aug 14, 2018

BUY
$71.74 - $153.69 $3.73 Million - $7.99 Million
52,000 New
52,000 $6.87 Million
Q1 2018

May 15, 2018

SELL
$54.02 - $82.27 $140,452 - $213,902
-2,600 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $92,897 - $122,590
2,600
2,600 $118,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.